Study Examines Weight Loss and Atrial Fibrillation Recurrence
A new randomized trial published in JAMA assessed whether weight loss reduces atrial fibrillation recurrence. Results differed based on whether the condition was chronic or recent in onset.
ncbi.nlm.nih.govA randomized trial published in JAMA examined whether weight loss reduces recurrence of atrial fibrillation. The study found that weight loss was unlikely to prevent recurrence in patients with chronic, persistent atrial fibrillation. For patients whose atrial fibrillation was new and lasted less than one year, weight loss showed a higher likelihood of preventing recurrence, consistent with an earlier randomized trial.
The findings distinguish outcomes by duration of the condition.
Key Facts
Potential Impact
- 01
Clinicians may adjust treatment recommendations for patients with recent atrial fibrillation.
Transparency Panel
Related Stories
NprWHO Director Visits Congo as Ebola Outbreak Spreads
The head of the World Health Organization arrived in Kinshasa to support efforts against a rare Ebola strain. Health workers face equipment shortages, community distrust, and armed conflict in affected provinces.
medpagetoday.comFDA Panel Recommends XFG Variant for Fall Covid Shots
Replimune will submit an application to the FDA for the third time. Pfizer and Innovent Biologics reached a collaboration agreement valued at up to $10.5 billion.
Benzinga Publishes Article on Biotech Stocks During Pandemic Recovery
Benzinga published an article titled 'Best Biotech Stocks Right Now' that addresses the sector's position during global recovery from the pandemic. The piece notes government institutions and professional traders are focusing on biotech companies for vaccine and booster developme…